Nebius Group (NBIS) PT Raised to $144 at Morgan Stanley
Tweet
Share
E-mailGet Alerts NBIS Hot Sheet
Price: $286.69 --0%
Rating Summary:
10 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 15 | Down: 5 | New: 19
Rating Summary:
10 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 15 | Down: 5 | New: 19
Join SI Premium – FREE
Morgan Stanley analyst Josh Baer raised the price target on Nebius Group (NASDAQ: NBIS) to $144.00 (from $126.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Ocular Therapeutix (OCUL) PT Raised to $25 at H.C. Wainwright
- Neumora Therapeutics (NMRA) PT Lowered to $4 at Mizuho
- Dutch Bros Inc. (BROS) PT Raised to $68 at Piper Sandler
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
